comparemela.com

Latest Breaking News On - Protective biosystems - Page 1 : comparemela.com

DARPA-funded fabric protects against chemical, biologic threats -- Defense Systems

By Nick Wakeman Apr 27, 2021 The Defense Advanced Research Projects Agency is developing new fabrics and protective equipment that can reduce the risk of chemical and biological threats to service members and responders. FLIR Systems was awarded a contract potentially worth more than $20 million under DARPA’s Personalized Protective Biosystems program. Under the PPB award, FLIR will rapidly develop fabrics with embedded catalysts and chemicals that can be incorporated into boots, gloves and eye protection, company officials said. Teams led by Leidos and Charles River Analytics were also awarded PPB contracts. The PPB program aims to reduce the weight, heat and physiological burden of the current personal protective equipment soldiers and health care workers must wear. By combining lightweight protective materials with prophylactic medical technologies, FLIR aims to mitigate chemical and biological threats to the eyes, skin and lungs, company officials said. The complete system

PREMIUM: DARPA funds research into next-generation PPE - Defence Notes

20th April 2021 - 11:45 GMT | by Gerrard Cowan in Belfast RSS Conceptual solution from FLIR Systems for the DARPA Personalized Protective Biosystems programme. (Photo: FLIR Systems) DARPA is working with industry on unburdening the warfighter by developing advanced and ultra-lightweight personal protective equipment. Its Personalized Protective Biosystems programme pre-dates COVID-19, but it arguably assumes even greater importance for defence procurement in the context of the pandemic. The DARPA Personalized Protective Biosystems (PBB) programme pre-dates the pandemic but it focuses on developing new fabrics to reduce the weight of PPE against . Want to read more? To read this article, along with thousands of others like it, start your Premium News free trial.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.